Nanometer slow-release agent based on phytic acid-polydopamine-metal ions and application of nanometer slow-release agent
Through phytic acid-polydopamine-metal ion nanosuspended release agent, the problem of uncontrollable differentiation direction of neural stem cells is solved, and the directional differentiation of neural stem cells to astrocytes is achieved, which improves bioavailability and is of great therapeutic significance. .
Patent Information
- Application Number
- CN202411235426.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art is difficult to effectively regulate the differentiation direction of neural stem cells, especially the directional differentiation towards astrocytes, and the bioavailability of phytic acid is low, making it difficult to play a potential role in the treatment of neurological diseases.
Using nanosustained release agents of phytic acid-polydopamine-metal ions, the dopamine molecule is used as a coordination intermediate to combine phytic acid and metal ions (Cu2+, Ag+, Fe3+, Al3+) to prepare a slow-down under weak acid conditions. Nano-sustained-release agents with release ability promote the directed differentiation of neural stem cells into astrocytes.
This nano-sustained-release agent can successfully enter the cells and slowly release phytic acid and metal ions in the lysosomes, improving the differentiation effectiveness and directional regulation capabilities of neural stem cells, and is of great significance to the treatment of neurological diseases based on stem cell therapy.
Smart Images

Figure CN119015435A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, and in particular to a nano sustained-release agent based on phytic acid-polydopamine-metal ions and applications thereof. Background Art
[0002] Stem cell therapy is a method that uses the pluripotency and self-renewal ability of stem cells to treat various diseases and injuries. It has shown broad application prospects in regenerative medicine, tissue engineering and disease treatment. Neural stem cells are a type of cell with self-renewal and multidirectional differentiation potential. They can differentiate into specific neural cells, including neurons and glial cells. These cells can replace degenerated functional cells and rebuild the functional circuits of the nervous system. Therefore, transplanting neural stem cells to replace diseased or damaged neural cells has great therapeutic potential for nervous system diseases. Although neural stem cells have great potential and can be used to treat nervous system diseases and injuries, there are still many problems and challenges in their differentiation regulation process. For example: the differentiation efficiency of neural stem cells into specific neural cells (such as neurons, astrocytes and oligodendrocytes) is low; the direction of neural stem cells during differentiation is uncontrollable and may produce unnecessary or undesirable cell types; the differentiation process of neural stem cells requires precise spatiotemporal regulation, etc. These problems greatly limit the safety and effectiveness of neural stem cells in therapeutic applications.
[0003] At present, the methods for regulating the differentiation of neural stem cells mainly include chemical signals, biological signals, gene editing, physical signals, etc. Chemical signals represented by small molecule compounds play an irreplaceable role in regulating stem cell differentiation. For example, patent application number 202210765632.1 discloses a retinoic acid-calcium nano sustained-release agent and its application in promoting the differentiation of stem cells into neurons. 2+ Combined with the construction of nano sustained-release agents, they can be slowly degraded under the weakly acidic microenvironment of lysosomes to release small molecules of retinoic acid and Ca 2+ , achieving rapid and precise regulation of neural stem cells in time and space dimensions. However, this nano sustained-release agent can only promote the differentiation of neural stem cells into neurons. In addition to neurons, neural cells also include astrocytes and oligodendrocytes, but there are few reports on promoting the directional differentiation of neural stem cells into astrocytes.
[0004] Phytic acid is called inositol hexaphosphate. Its excellent antioxidant and anti-inflammatory properties play a potential neuroprotective role in neurological diseases, but there are no reports on the use of phytic acid to regulate the differentiation of neural stem cells. However, when phytic acid is directly added to the extracellular culture medium, the process of phytic acid molecules acting on cells mainly depends on concentration diffusion, and phytic acid molecules may also bind to metal ions in the solution, which makes the bioavailability of phytic acid low. Therefore, exploring a phytic acid-based delivery strategy to improve the cellular utilization of phytic acid and thereby achieve targeted regulation of neural stem cell differentiation is of great significance for the treatment of neurological diseases based on stem cell therapy. Summary of the invention
[0005] In view of the above prior art, the present invention aims to provide a nano sustained-release agent based on phytic acid-polydopamine-metal ions and its application. The present invention uses dopamine molecules as coordination intermediates to form a nano sustained-release agent based on phytic acid-polydopamine-metal ions. 2+ 、Ag + , Fe 3+ 、Al 3+ ) to produce a nano sustained-release agent with sustained-release ability under weakly acidic conditions. After phytic acid-polydopamine-metal ion composite nanoparticles enter cells through endocytosis, they can be decomposed and slowly release phytic acid small molecules and metal ions under the action of the weakly acidic microenvironment of lysosomes, which can promote the directional differentiation of neural stem cells into astrocytes, and have important significance for the treatment of nervous system diseases based on stem cell therapy.
[0006] To achieve the above object, the present invention adopts the following technical solution: The first aspect of the present invention provides a nano sustained-release agent of phytic acid-polydopamine-metal ions, wherein the nano sustained-release agent of phytic acid-polydopamine-metal ions uses dopamine as a coordination intermediate to combine phytic acid and metal ions; The phytic acid-polydopamine-metal ion nano sustained-release agent can release phytic acid molecules and metal ions when the pH value is 5.5.
[0007] Preferably, the metal ion is selected from Cu 2+ 、Ag + , Fe 3+ or Al 3+ .
[0008] The second aspect of the present invention provides a method for preparing a nano sustained-release agent of phytic acid-polydopamine-metal ions, comprising the following steps: The dopamine aqueous solution is added to the phytic acid aqueous solution, heated and stirred, and then the metal ion aqueous solution is added, and the pH is adjusted to alkaline with alkali solution, and the reaction is continued. After the reaction is completed, centrifugation, washing, and freeze-drying are performed to obtain a phytic acid-polydopamine-metal ion nano sustained-release agent.
[0009] Preferably, the dopamine aqueous solution is obtained by dissolving dopamine in double distilled water; the phytic acid aqueous solution is obtained by dissolving phytic acid in double distilled water; and the metal ion aqueous solution is obtained by using a metal salt as a metal ion source and dissolving the metal salt in double distilled water.
[0010] Preferably, the concentration of the metal ion aqueous solution is 0.4M; the concentration of the dopamine aqueous solution is 0.2M; and the concentration of the phytic acid aqueous solution is 0.1M.
[0011] Preferably, the molar ratio of the metal salt, dopamine and phytic acid is 4-16:2-4:1.
[0012] Preferably, the alkali solution is a NaOH solution; the concentration of the NaOH solution is 1 M; and the pH is adjusted to 9.0 using the alkali solution.
[0013] Preferably, the heating temperature is 60° C., and the heating time is 30 min; the continuing reaction temperature is 60° C., and the continuing reaction time is 1 to 2 h.
[0014] The third aspect of the present invention provides the use of a nano sustained-release agent of phytic acid-polydopamine-metal ions in at least one of the following 1)-3): 1) Promote the differentiation of neural stem cells into astrocytes; 2) Preparation of culture medium to promote the differentiation of neural stem cells into astrocytes; 3) Prepare drugs that promote the differentiation of neural stem cells into astrocytes.
[0015] Beneficial effects of the present invention: (1) The present invention combines phytic acid small molecules with different metal ions (Cu 2+ 、Ag + , Fe 3+ 、Al 3+ ) and innovatively used dopamine molecules as coordination intermediates to prepare a nano sustained-release agent with sustained-release ability under weakly acidic conditions through self-assembly. The nano sustained-release agent can be successfully endocytosed by stem cells into the cell lysosome. In the weakly acidic microenvironment of the lysosome (pH~5.5), the nano sustained-release agent is decomposed and slowly releases free phytic acid molecules and metal ions. This nano-scale strategy successfully achieved the internalization of the effective components by cells and improved the effectiveness of subsequent cell differentiation.
[0016] (2) The phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention has good cell compatibility and can promote the directional differentiation of stem cells. The phytic acid-polydopamine-metal ion nano sustained-release agent of the present invention acts on neural stem cells to regulate the differentiation of neural stem cells into astrocytes. This provides a novel method for the directional differentiation of stem cells, which is of great significance for the development of stem cell therapy for the treatment of nervous system diseases. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 : Microscopic morphology characterization (SEM) of the phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention, wherein: (a) SEM of phytic acid-polydopamine-copper; (b) SEM of phytic acid-polydopamine-silver; Figure 2 : Chemical structure analysis (FTIR) of the phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention; Figure 3 : The decomposition and release curves of the phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention in a lysosome simulation solution (pH~5.5); wherein, (a) the decomposition and release curve of phytic acid-polydopamine-copper; (b) the decomposition and release curve of phytic acid-polydopamine-silver; Figure 4 : The co-localization staining picture of the phytic acid-polydopamine-metal ion composite nano sustained-release agent and the lysosome of neural stem cells; Figure 5 : The effect of the phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention on the proliferation activity of neural stem cells (CCK8 detection); wherein, (a) the effect of phytic acid-polydopamine-copper on the proliferation activity of neural stem cells; (b) the effect of phytic acid-polydopamine-silver on the proliferation activity of neural stem cells; (c) the effect of phytic acid-copper on the proliferation activity of neural stem cells; (d) the effect of PDA on the proliferation activity of neural stem cells; (e) the effect of phytic acid-polydopamine-calcium on the proliferation activity of neural stem cells; Figure 6 : The regulatory effect of the phytic acid-polydopamine-metal ion composite nano sustained-release agent of the present invention on the differentiation of nerve trunks, including: (a) immunofluorescence staining images (neurons and astrocytes), (b) quantitative analysis of the fluorescence intensity of GFAP, and (c) quantitative analysis of the fluorescence intensity of Tuj1. DETAILED DESCRIPTION
[0018] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0019] As introduced in the background technology section, stem cells have the problem of uncontrollable differentiation direction. Existing differentiation methods and technologies make it difficult to achieve precise differentiation of stem cells, which limits the safety and effectiveness of their application in neural repair. Small molecule compounds are an effective method for regulating stem cell differentiation. They are often dissolved or added to culture medium for cell treatment. In addition, small molecule compounds have problems such as poor stability, low targeting, and short half-life, which makes small molecule compounds have low bioavailability in the process of intervening in stem cell differentiation.
[0020] Based on this, the purpose of the present invention is to provide a nano sustained-release agent based on phytic acid-polydopamine-metal ions and its application. Based on the inherent physicochemical properties of phytic acid, the present invention uses dopamine molecules as coordination intermediates, self-assembles phytic acid small molecules with different metal ions, and prepares a phytic acid-polydopamine-metal ion nano sustained-release agent with pH responsiveness. Dopamine polymerizes into polydopamine when connecting phytic acid and metal ions. The process of mixing dopamine and phytic acid does not react. After adding metal ions, it is adjusted to weak alkaline conditions, and then dopamine polymerizes into polydopamine during the coordination reaction. In a weakly acidic environment, after phytic acid-polydopamine-metal ion nanoparticles enter cells through endocytosis, they can be slowly degraded under the action of lysosomes to release phytic acid small molecules and metal ions; the remaining polydopamine will not decompose into dopamine, but only release the metal and phytic acid on the polymerization chain. Polydopamine will not decompose under weak acid conditions, and cannot induce neural stem cells to differentiate into astrocytes when used alone. However, when used together with phytic acid and metal ions, it can increase the proportion of neural stem cells differentiating into astrocytes. The release of effective components in cells can regulate the differentiation of stem cells in a directional manner in terms of time and space, and promote the directional differentiation of neural stem cells into astrocytes.
[0021] In order to enable those skilled in the art to more clearly understand the technical solution of the present application, the technical solution of the present application will be described in detail below in conjunction with specific embodiments.
[0022] Note: The manufacturer of the phytic acid used in the present invention is McLean, and the model specification is P816021 phytic acid, 50% solution (mass concentration is 50%).
[0023] The test materials used in the examples of the present invention are all conventional test materials in the art and can be purchased through commercial channels.
[0024] Example 1: Preparation of phytic acid-polydopamine-copper composite nano sustained-release agent (1) Dissolve 3.2 g of copper sulfate in 50 mL of ddH2O and stir until fully dissolved. This is called solution A. Dissolve 6.6 g of phytic acid (50% w / w) in 50 mL of ddH2O and stir until fully dissolved. This is called solution B. Dissolve 1.53 g of dopamine in 50 mL of ddH2O and stir until fully dissolved. This is called solution C.
[0025] (2) Add solution C to solution B, stir at 60°C for 30 min, then add solution A dropwise to the mixed solution at a rate of 5 mL / min, stirring while adding. The molar ratio of copper sulfate to phytic acid in the mixed solution is 4:1, and the molar ratio of dopamine to phytic acid is 2:1. Use 1 M NaOH to adjust the pH value of the mixed solution to 9.0.
[0026] (3) The mixed solution was placed in a 60 °C water bath and stirred at 600 rpm for 2 h. The mixed solution became gray and turbid.
[0027] (4) The product was collected by centrifugation, washed three times with double distilled water, and vacuum freeze-dried for 24 h to obtain phytic acid-polydopamine-copper (PA-PDA-Cu) nano sustained-release agent material.
[0028] Example 2: Preparation of phytic acid-polydopamine-silver composite nano sustained-release agent (1) Dissolve 13.6 g of silver nitrate in 50 ml of ddH2O and stir until fully dissolved. This is called solution A. Dissolve 6.6 g of phytic acid (50% w / w) in 50 ml of ddH2O and stir until fully dissolved. This is called solution B. Dissolve 3.06 g of dopamine in 50 mL of ddH2O and stir until fully dissolved. This is called solution C.
[0029] (2) Add solution C to solution A, stir at 60°C for 30 min, then add solution A dropwise to the mixed solution at a rate of 5 mL / min, stirring while adding. The molar ratio of silver nitrate to phytic acid in the mixed solution is 16:1, and the molar ratio of dopamine to phytic acid is 4:1. The pH value of the mixed solution is adjusted to 9.0 with 1 M NaOH.
[0030] (3) The mixed solution was placed in a 60 °C water bath and stirred at 600 rpm for 2 h. The mixed solution became gray and turbid.
[0031] (4) The product was collected by centrifugation, washed three times with double distilled water, and vacuum freeze-dried for 24 h to obtain phytic acid-polydopamine-silver (PA-PDA-Ag) nano sustained-release agent material.
[0032] Comparative Example 1 The difference from Example 1 is that no dopamine aqueous solution is added: (1) Dissolve 3.2 g of copper sulfate in 50 mL of ddH2O and stir until fully dissolved. This is called solution A. Dissolve 6.6 g of phytic acid (50% w / w) in 50 mL of ddH2O and stir until fully dissolved. This is called solution B.
[0033] (2) Add solution A to solution B at a rate of 5 ml / min while stirring. The molar ratio of copper sulfate to phytic acid in the mixed solution is 4:1, and the pH value of the mixed solution is adjusted to 9.0 with 1 M NaOH.
[0034] (3) The mixed solution was placed in a 60°C water bath and stirred at 600 rpm for 2 h. The mixed solution became light blue and turbid.
[0035] (4) The product was collected by centrifugation, washed three times with double distilled water, and vacuum freeze-dried for 24 h to obtain phytic acid-copper (PA-Cu) nano sustained-release agent material.
[0036] Comparative Example 2 Preparation of polydopamine nanoparticles (1) Dissolve 3.06 g of dopamine in 100 mL of ddH2O, stir to fully dissolve, and adjust the pH of the solution to 9.0 with 1 M NaOH.
[0037] (2) The mixture was placed in a 60°C water bath and stirred at 600 rpm for 2 h. The reaction mixture became gray-black and turbid.
[0038] (3) The product was collected by centrifugation, washed three times with double distilled water, and vacuum freeze-dried for 24 h to obtain polydopamine (PDA) nanoparticles.
[0039] Comparative Example 3: Preparation of phytic acid-polydopamine-calcium nano sustained-release agent (1) Dissolve 1.48 g of calcium hydroxide in 50 mL of ddH2O and stir until fully dissolved. This is called solution A. Dissolve 6.6 g of phytic acid (50% w / w) in 50 mL of ddH2O and stir until fully dissolved. This is called solution B. Dissolve 1.53 g of dopamine in 50 mL of ddH2O and stir until fully dissolved. This is called solution C.
[0040] (2) Add solution C to solution B, stir at 60°C for 30 min, then add solution A dropwise to the mixed solution at a rate of 5 ml / min, stirring while adding. The molar ratio of calcium hydroxide to phytic acid in the mixed solution is 4:1, and the molar ratio of dopamine to phytic acid is 2:1. Use 1 M NaOH to adjust the pH value of the mixed solution to 9.0.
[0041] (3) The mixed solution was placed in a 60°C water bath and stirred at 600 rpm for 2 h. The mixed solution became gray and turbid.
[0042] (4) The product was collected by centrifugation, washed three times with double distilled water, and freeze-dried in a vacuum oven for 24 h to obtain a phytic acid-polydopamine-calcium (PA-PDA-Ca) nano sustained-release agent.
[0043] Characterization The samples of Example 1 and Example 2 were analyzed and characterized (morphology, chemical structure and pH responsiveness) and verified for cell internalization. Figure 1 , SEM imaging shows the microscopic morphology of different phytic acid-polydopamine-metal ion nano sustained-release agents. It can be seen that the morphology of phytic acid-polydopamine-copper is nanosheets with a size of about 100nm, and the morphology of phytic acid-polydopamine-silver is nanospheres with a size of about 50nm. Figure 2 FTIR spectrum showed that phytic acid (-OH, C=C, HPO4 2- PO4 3- ) and polydopamine (-OH, C=C), but the intensity of some peaks has weakened or increased. The stretching vibration peak of -OH and HPO4 2- The vibration peak of PO4 3- The vibration peaks of the C=C of the benzene ring skeleton were significantly enhanced, indicating that the phosphate group in phytic acid participated in the coordination reaction and combined with metal ions and dopamine. The decomposition and release of different phytic acid-polydopamine-metal ion nanoparticles prepared were verified by simulating the weak acid microenvironment of cell lysosomes. Figure 3 The results showed that when the pH value of the system dropped from 7.0 to 5.5, the phytic acid-polydopamine-metal ion nanoparticles could slowly release metal ions under weakly acidic conditions, indicating that the phytic acid-polydopamine-metal ion composite nanoparticles prepared by the present invention have low pH responsiveness. In addition, the endocytosis of neural stem cells to the phytic acid-polydopamine-metal ion composite nano sustained-release agent was further verified. Neural stem cells were inoculated in a 48-well plate and cultured for 12 h, and then the nanoparticles in Example 1 and Example 2 labeled with rhodamine were incubated for another 6 h, and Lyso tracker was used to detect the phytic acid-polydopamine-metal ion composite nanoparticles. TM After 30 min of dye treatment, confocal laser scanning microscopy was used to observe the endocytosis of nanoparticles by cells. Figure 4 As shown, it can be observed that the nanoparticles (red) enter the interior of the cells and co-localize with the intracellular lysosomes (blue), indicating that neural stem cells can successfully internalize phytic acid-polydopamine-metal nanoparticles, providing a possibility for inducing subsequent biological responses and regulating cell differentiation.
[0044] Test example: 1. Effect of phytic acid-polydopamine-metal ion composite nano-sustained release agent on the proliferation activity of neural stem cells The materials prepared in Examples 1-2 and Comparative Examples 1-3 were added to a neural stem cell proliferation medium (Neurobasal medium, 2% B27 factor, 20ng / mL EGF growth factor, 20ng / mL bFGF growth factor, 1% glutamine, 1% double antibody) to make the material concentration be 12.5μg / mL-1000μg / mL; at the same time, each group was controlled with a neural stem cell proliferation medium that did not contain nano sustained-release agent materials. Neural stem cells (mouse hippocampus, from the stem cell and tissue engineering laboratory of the Institute of Frontier Interdisciplinary Sciences of Jinan University) were placed in proliferation medium containing the materials prepared in Examples 1-2 and Comparative Examples 1-3, respectively. After culturing for 1, 3, and 5 days, respectively, the cell survival rate was detected using a CCK8 kit. Figure 5 As shown, the effects of various nanoparticles on the proliferation activity of neural stem cells at different concentrations were investigated. Figure 5 =The number of surviving cells at each concentration in each group on the Nth day / the number of cells in the control group on the first day. When the concentrations of phytic acid-polydopamine-copper nanoparticles and phytic acid-polydopamine-silver nanoparticles were less than 200μg / mL, neural stem cells showed good proliferation activity, which was significantly higher than that of the control group. Similarly, when the concentration of phytic acid-copper nanoparticles was less than 200μg / mL, neural stem cells showed a good proliferation trend. However, polydopamine nanoparticles had no concentration dependence on the cell activity of neural stem cells, and their cell proliferation trend was consistent with that of the control group. For phytic acid-polydopamine-calcium nanoparticles, when the concentration was lower than 400μg / mL, neural stem cells had good proliferation activity, and there was no significant difference from the control group. The above results show that when phytic acid-polydopamine-metal ion nanoparticles are in a specific concentration range, they have good compatibility with neural stem cells, and the safe concentration ranges of different metal ion groups are different.
[0045] 2. Regulatory effect of phytic acid-polydopamine-metal ion composite nano-sustained release agent on the directional differentiation of neural stem cells The effect of phytic acid-polydopamine-metal ion composite nano sustained-release agent on the differentiation of neural stem cells was investigated. According to the above cell compatibility results, 50 μg / mL was selected as the material treatment concentration. Neural stem cells (mouse hippocampus, from the stem cell and tissue engineering laboratory of the Institute of Frontier Interdisciplinary Sciences of Jinan University) were treated with a differentiation medium (Neurobasal medium, 2% B27 factor, 2% FBS, 1% double antibody) containing the materials prepared in Examples 1 to 2 and Comparative Examples 1 to 3 (material concentration is 50 μg / mL). Neural stem cells were added to the differentiation medium containing the materials prepared in Examples 1 to 2 and Comparative Examples 1 to 3 to induce differentiation. On the 7th day of the induced differentiation treatment, the expression of related proteins in the differentiated cells was detected by immunofluorescence staining. Figure 6 As shown in the figure, the differentiated cells were Tuj1 positive (neurons) and GFAP positive (astrocytes), indicating that neural stem cells have the ability to differentiate into a variety of neural cells. Through immunofluorescence imaging and quantitative analysis of fluorescence intensity, it can be seen that the phytic acid-polydopamine-copper and phytic acid-polydopamine-silver particle groups showed more astrocytes, while the phytic acid-polydopamine-calcium particle group showed more neurons. This result shows that the introduction of metal ions copper and silver promotes the differentiation of neural stem cells into astrocytes, while calcium ions regulate the differentiation of neural stem cells into neurons. Although phytic acid-copper nanoparticles also regulate the differentiation of neural stem cells into astrocytes, the addition of dopamine as a coordination intermediate enhances the coordination binding efficiency of phytic acid molecules and copper ions, thereby significantly improving the differentiation rate of neural stem cells into astrocytes. In addition, it was found that polydopamine nanoparticles alone cannot regulate the differentiation of neural stem cells into glial cells but are more inclined to neuronal differentiation. The above results show that the phytic acid-polydopamine-metal ion nano-regulators in Examples 1 and 2 can perform targeted intervention on the differentiation of neural stem cells and have superiority in regulating the differentiation of neural stem cells into astrocytes.
[0046] In summary, the phytic acid-polydopamine-metal ion nano sustained-release agent material prepared by the present invention can be successfully internalized by neural stem cells, and releases active components in the intracellular low pH microenvironment, thereby regulating the directional differentiation of neural stem cells into astrocytes.
[0047] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A nano sustained-release agent of phytic acid-polydopamine-metal ions, characterized in that: The phytic acid-polydopamine-metal ion nano sustained-release agent uses dopamine as a coordination intermediate to combine phytic acid and metal ions; The phytic acid-polydopamine-metal ion nano sustained-release agent can release phytic acid molecules and metal ions when the pH value is 5.
5.
2. The nano sustained-release agent according to claim 1, characterized in that: The metal ion is selected from Cu 2+ 、Ag + , Fe 3+ or Al 3+ .
3. The method for preparing the nano sustained-release agent according to claim 1 or 2, characterized in that: The following steps are involved: The dopamine aqueous solution is added to the phytic acid aqueous solution, heated and stirred, and then the metal ion aqueous solution is added, and the pH is adjusted to alkaline with alkali solution, and the reaction is continued. After the reaction is completed, centrifugation, washing, and freeze-drying are performed to obtain a phytic acid-polydopamine-metal ion nano sustained-release agent.
4. The preparation method according to claim 3, characterized in that: The dopamine aqueous solution is obtained by dissolving dopamine in double distilled water; the phytic acid aqueous solution is obtained by dissolving phytic acid in double distilled water; and the metal ion aqueous solution is obtained by taking a metal salt as a metal ion source and dissolving the metal salt in double distilled water.
5. The preparation method according to claim 4, characterized in that: The concentration of the metal ion aqueous solution is 0.4M; the concentration of the dopamine aqueous solution is 0.2M; and the concentration of the phytic acid aqueous solution is 0.1M.
6. The preparation method according to claim 5, characterized in that: The molar ratio of the metal salt, dopamine and phytic acid is 4-16:2-4:
1.
7. The preparation method according to claim 3, characterized in that: The alkali solution is a NaOH solution; the concentration of the NaOH solution is 1 M; the pH is adjusted to 9.0 using the alkali solution.
8. The preparation method according to claim 3, characterized in that: The heating temperature is 60° C., and the heating time is 30 min; the continuing reaction temperature is 60° C., and the continuing reaction time is 1-2 h.
9. Use of the nano sustained-release agent according to claim 1 or 2 in at least one of the following 1) to 3): 1) Promote the differentiation of neural stem cells into astrocytes; 2) Preparation of culture medium to promote the differentiation of neural stem cells into astrocytes; 3) Prepare drugs that promote the differentiation of neural stem cells into astrocytes.
